These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3780108)
1. Plasma and erythrocyte copper, zinc, manganese and magnesium concentrations in Wilson's disease. Goto I; Kawano Y; Tsuchiya T; Tamagawa Y; Kuroiwa Y Clin Neurol Neurosurg; 1986; 88(3):193-6. PubMed ID: 3780108 [TBL] [Abstract][Full Text] [Related]
2. [The onset of psychiatric disorders and Wilson's disease]. Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784 [TBL] [Abstract][Full Text] [Related]
3. Serum copper, ceruloplasmin and 24-h urine copper evaluations in celiac patients. Ince AT; Kayadibi H; Soylu A; Ovunç O; Gültepe M; Toros AB; Yaşar B; Kendir T; Abut E Dig Dis Sci; 2008 Jun; 53(6):1564-72. PubMed ID: 17934856 [TBL] [Abstract][Full Text] [Related]
4. A study on the concentrations of serum zinc, non-ceruloplasmin copper, reactive oxygen and nitrogen species in children with Wilson's disease. Geetha A; Jeyachristy SA; Selvamathy SM; Ilavarasi S; Surendran R Clin Chim Acta; 2007 Aug; 383(1-2):165-7. PubMed ID: 17573059 [No Abstract] [Full Text] [Related]
6. Zinc and tetrathiomolybdate for the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases. Brewer GJ Metallomics; 2009; 1(3):199-206. PubMed ID: 21305118 [TBL] [Abstract][Full Text] [Related]
7. The role of calculated non-caeruloplasmin-bound copper in Wilson's disease. Duncan A; Yacoubian C; Beetham R; Catchpole A; Bullock D Ann Clin Biochem; 2017 Nov; 54(6):649-654. PubMed ID: 27742851 [TBL] [Abstract][Full Text] [Related]
8. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease. Boaru SG; Merle U; Uerlings R; Zimmermann A; Flechtenmacher C; Willheim C; Eder E; Ferenci P; Stremmel W; Weiskirchen R J Cell Mol Med; 2015 Apr; 19(4):806-14. PubMed ID: 25704483 [TBL] [Abstract][Full Text] [Related]
9. Copper and zinc in the serum, urine, and hair of patients with Wilson's disease treated with penicillamine and zinc. Dastych M; Procházková D; Pokorný A; Zdrazil L Biol Trace Elem Res; 2010 Mar; 133(3):265-9. PubMed ID: 19562272 [TBL] [Abstract][Full Text] [Related]
10. The effects of iron and zinc status on prognosis in pediatric Wilson's disease. Güngör Ş; Selimoğlu MA; Varol Fİ; Güngör S; Üremiş MM J Trace Elem Med Biol; 2019 Sep; 55():33-38. PubMed ID: 31345362 [TBL] [Abstract][Full Text] [Related]
11. Significance of copper determination in late onset of Wilson's disease. Lech T; Hydzik P; Kosowski B Clin Toxicol (Phila); 2007 Sep; 45(6):688-94. PubMed ID: 17849244 [TBL] [Abstract][Full Text] [Related]
12. Population screening for Wilson's disease. Hahn SH Ann N Y Acad Sci; 2014 May; 1315():64-9. PubMed ID: 24731025 [TBL] [Abstract][Full Text] [Related]
13. Wilson's disease in two consecutive generations: the detection of three mutated alleles in the ATP7B gene in two Sardinian families. Loudianos G; Zappu A; Lepori MB; Incollu S; Dessì V; Mameli E; Garrucciu G; De Virgiliis S; Cao A Dig Liver Dis; 2013 Apr; 45(4):342-5. PubMed ID: 23219664 [TBL] [Abstract][Full Text] [Related]
14. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Merle U; Schaefer M; Ferenci P; Stremmel W Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660 [TBL] [Abstract][Full Text] [Related]
15. Contribution to the data on copper concentration in blood and urine in patients with Wilson's disease and in normal subjects. Lech T; Sadlik JK Biol Trace Elem Res; 2007 Jul; 118(1):16-20. PubMed ID: 17848726 [TBL] [Abstract][Full Text] [Related]